Isolation, Structure Elucidation, and Bioactivity Evaluation of Secondary Metabolites From Vachellia farnesiana (L.) Wight & Arn.
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202500553 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Md Sadman Hasib und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Department of Pharmaceutical Chemistry, University of Dhaka, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Plant Extracts, Anti-Bacterial Agents, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Vachellia farnesiana is a medicinal plant rich in bioactive compounds, long used in traditional medicine. Its therapeutic potential includes addressing cancer, diabetes, and antibiotic‐resistant infections, making it a promising candidate for drug discovery. This study focused on isolating active compounds from the n ‐hexane and dichloromethane (DCM) fractions of the plant's ethanolic extract employing size exclusion chromatography and nuclear magnetic resonance (NMR) spectroscopy. It also aimed to assess their potential antimicrobial, antidiabetic, and cytotoxic activities while validating traditional uses through experimental and computational approaches. The biological activities of these compounds were tested through cytotoxicity and antimicrobial assays, glucose‐lowering experiments in mice, and molecular docking to simulate interactions with disease‐related proteins. Five compounds were isolated, including β‐amyrin, 7β‐hydroxysitosterol, oleanolic acid, lauric acid, and viscic acid. Notable findings include high cytotoxicity (LC 50 = 0.231 µg/mL for the n ‐hexane fraction), antimicrobial activity with inhibition zones reaching 19 mm, and a 57.53% reduction in blood glucose levels (DCM fraction, 400 mg/kg, 3 h). Molecular docking demonstrated strong binding affinities for the isolated compounds against targeted receptors. This research validates V. farnesiana ’s traditional medicinal uses and emphasizes its potential as a source of novel treatments for chronic diseases and infections and paves the way for future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Department of Pharmaceutical Chemistry, University of Dhaka, Dhaka, Bangladesh.
- Faculty of Health and Life Sciences (FHLS), Department of Pharmacy, Daffodil International University, Daffodil Smart City, Dhaka, Bangladesh.
- Department of Pharmacy, University of Asia Pacific, 74/A Green Road, Dhaka, Bangladesh.
- Chemical Research Division, BCSIR Dhaka Laboratories, Bangladesh Council of Scientific and Industrial Research (BCSIR), Dhaka, Bangladesh.
ORCID-Profile: Md Sadman Hasib, Fahmida Tasnim Richi, Safaet Alam, Md Sazzadul Bari, Mohammad A Rashid
Zitieren
APA
Hasib, M. S., Richi, F. T., Alam, S., Bari, M. S., Rashid, M. A., & Hossain, M. A. (2025). Isolation, Structure Elucidation, and Bioactivity Evaluation of Secondary Metabolites From Vachellia farnesiana (L.) Wight & Arn. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202500553
Vancouver
Hasib MS, Richi FT, Alam S, Bari MS, Rashid MA, Hossain MA. Isolation, Structure Elucidation, and Bioactivity Evaluation of Secondary Metabolites From Vachellia farnesiana (L.) Wight & Arn. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202500553
BibTeX
@article{Hasib2025,
author = {Hasib, Md Sadman and Richi, Fahmida Tasnim and Alam, Safaet and Bari, Md Sazzadul and Rashid, Mohammad A and Hossain, Md Aslam},
title = {Isolation, Structure Elucidation, and Bioactivity Evaluation of Secondary Metabolites From Vachellia farnesiana (L.) Wight & Arn},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202500553}
}
EUVIMED